Compugen to Present UnigenX™ Platform at the 18th Annual PEGS Europe Summit
What Compugen (CGEN) Said on Its Q3 Earnings Call
Compugen (NASDAQ:CGEN) Q3 2026 Beat Shifts Focus to 2027 Pipeline Readouts
Compugen (CGEN) Reports Q3 Loss, Beats Revenue Estimates
Compugen: Q3 Earnings Snapshot
Compugen Ltd. (CGEN) Q3 2026 Earnings Call Transcript
Compugen Q3 EPS $(0.06) Beats $(0.08) Estimate, Sales $3.821M Beat $1.700M Estimate
Compugen to Participate in November Investor Conferences
Compugen to Release Third Quarter 2026 Results on Monday, November 9, 2026
HC Wainwright & Co. Reiterates Buy on Compugen, Maintains $4 Price Target
Compugen to Participate in a Fireside Chat at the H.C. Wainwright 3rd Annual AI Based Drug Discovery & Development Conference
Compugen Ltd. (CGEN) Discusses COM701 in Ovarian Cancer, MAIA Trial Preview, and UNIGEN Platform Advancements Transcript
Compugen to Host Virtual KOL Event on COM701 in Ovarian Cancer & Unigen™ Platform Update on October 5, 2026
Compugen to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference
All You Need to Know About Compugen (CGEN) Rating Upgrade to Buy
Compugen: Better Runway Ahead Of MAIA
Compugen Ltd (CGEN) (Q2 2026) Earnings Call Highlights: Advancing COM701 with Strong Cash ...
Compugen Q2 Earnings Call Highlights
Compugen Ltd. (CGEN) Q2 2026 Earnings Call Transcript
Compugen Q2 EPS $(0.07), Inline, Sales $2.602M Beat $1.606M Estimate
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.